Match Document Document Title
US20140037719 STABILIZED PHARMACEUTICAL FORMULATIONS OF A POTENT HCV INHIBITOR  
Described are various methods for stabilizing pharmaceutical formulations of a specific Hepatitis C Viral (HCV) inhibitor against the formation of a particular genotoxic degradation product. Such...
US20070014847 Coated capsules and methods of making and using the same  
The present invention relates to coated capsules with increased capsule shell pliability and resilience and methods of making the coated capsules. The present invention relates to methods of...
US20100255088 Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease  
A method for delivering a composition for use in treatment and prevention of vascular disease by providing a vehicle for delivery of the composition to an individual, wherein the composition...
US20050106233 Polysaccharide capsules and methods of preparation  
The present invention is directed to seamless capsules and methods for making seamless capsules having a high oil content. More specifically, the present invention is directed to seamless...
US20120251621 Nutritionally Enhanced Fraction From Rice Bran And Method of Lowering Insulin Resistance Using Same  
Nutritionally enhanced nutraceutical Hydrophilic and Lipophilic Rice Bran Fractions from rice bran are provided, as well as a method of using the same to reduce Insulin Resistance in animals,...
US20110045062 FORMULATION  
This invention relates to a formulation comprising a dipeptidylpeptidase IV (DPP-IV) inhibitor preferably vildagliptin and metformin, to tablets comprising such formulations and to processes for...
US20070134316 Soft capsule of butylphthalide and a process for preparing the same  
The present invention discloses a novel soft capsule of butylphthalide and a process for preparing the same. The soft capsule of butylphthalide is composed of a capsule wall material and a...
US20110091534 COMPOSITIONS COMPRISING POLYMERIC MICELLES FOR DRUG DELIVERY  
The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same.
US20110174653 CAPSULE WITH SOLUBLE BLOCKING ELEMENT  
The invention relates to a capsule comprising an inlet and an outlet connected by a passage, in which a dissolvable blocking element and a composition to be orally administered are arranged. The...
US20090155352 Microemulsion containing indolocarbazole compound and dosage forms containing the same  
The invention described herein provides a pharmaceutical composition and oral dosage forms containing the same, having high concentrations of solubilized indolocarbazole compounds as the active...
US20060275357 Organic compounds  
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S1P receptor agonist; and (b) a sugar alcohol.
US20150190523 BIOAVAILABILITY OF ORAL METHYLNALTREXONE INCREASES WITH A PHOSPHATIDYLCHOLINE-BASED FORMULATION  
A pharmaceutical composition comprising a phosphatidylcholine-based opioid receptor antagonist formulation, as well as methods of their use and methods of their preparation are provided herein....
US20140370083 5-AMINOSALICYLIC ACID CAPSULE FORMULATION  
A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is...
US20140141075 5-AMINOSALICYLIC ACID CAPSULE FORMULATION  
A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is...
US20080138406 COMPOSITION FOR TREATMENT OF PAIN IN BONES AND JOINTS  
The present invention is a composition delivering effective amounts of Glucosamine, Devils Claw, and SAM in a single dosage unit.
US20090028934 GRANULAR, GASTRO-RESISTANT PRODUCT BASED ON NIACIN OR DERIVATES THEREOF AND PROCESS FOR THE PRODUCTION OF SUCH A PRODUCT  
A granular, gastro-resistant product based on niacin or derivatives thereof comprises an internal part in which the niacin is substantially concentrated and an external coating, provided to cover...
US20070065502 Methods and apparatus for sealing capsules  
Methods and apparatus for providing a leak-proof seal for two-piece capsules containing oil-based liquids or other compositions by a two-stage process. The capsule cap and capsule body are...
US20050075335 Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation  
The invention provides a process for preparing a pharmaceutical composition comprising N-[(1-nbutyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazi no[3,2-a]indole-10-carbixamide (pharmaceutical...
US20150165049 17-Hydroxyprogesterone Ester Containing Oral Compositions and Related Methods  
The present invention provides for bioavailable oral dosage forms containing esters of 17-hydroxyprogesterone as well as related methods. The oral dosage forms can be formulated for pregnancy...
US20150246027 FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING DEFERASIROX AND DEFERIPRONE  
The present invention relates to a fixed dose pharmaceutical composition comprising iron chelating agents.
US20070292498 Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers  
Pharmaceutical compositions comprising a proton pump inhibitor, one or more buffering agent, a sleep aid and acetaminophen, ibuprofen, aspirin or naproxen are described. Methods are described for...
US20150110866 COMPLEXES AND COMPOSITIONS CONTAINING CURCUMIN  
A complex is provided, including a phospholipid and curcumin, wherein some or all of the phospholipid is a marine phospholipid. In addition, a composition is provided including a complex with a...
US20120276195 Indole Alkaloid Derivatives Having Opioid Receptor Agonistic Effect, And Therapeutic Compositions And Methods Relating To Same  
Indole alkaloid derivatives having an opioid receptor agonistic effect, their synthesis, and therapeutic compositions containing these derivatives, and methods of treating conditions with these...
US20050220866 Novel capsule formulations of etoposide for oral use  
The present invention relates to self microemulsifying pharmaceutical compositions comprising Etoposide that are encapsulated. The composition comprises (i) a drug phase comprising Etoposide, and...
US20070224258 Dosage forms having a randomized coating  
A pharmaceutical dosage form is provided comprising a core and a shell adherent thereto, wherein the shell is comprised of at least a first portion and a second portion, each of which is...
US20080175897 Dosage forms for administering combinations of drugs  
The present invention is directed to dosage forms that can be used in therapeutic methods involving the oral co-administration of a combination of at least two drugs, one of which impairs...
US20100055172 ENCAPSULATED SOY EXTRACTS AND PROCESS FOR PREPARING SAME  
Soy extracts encapsulated with oligosaccharides and processes for making the encapsulated soy extracts. The processes generally comprise combining a soy extract solution and an oligosaccharide...
US20070237815 DOSAGE FORMS AND METHODS COMPRISING AMLODIPINE AND CHLORTHALIDONE  
The subject invention provides compositions and methods of use of a single dosage form which includes therapeutic or subtherapeutic doses of a dihydropyridine calcium channel blocker (CCB), such...
US20070122398 Encapsulated hydrophilic compounds  
The present invention relates to capsules for encapsulating functional agents, such as flavors, fragrances, pharmaceuticals, vitamins, etc. The capsules are suitable for the encapsulation of...
US20130011468 FATTY ACID COMPOSITION FOR TREATMENT OF ALZHEIMER'S DISEASE AND COGNITIVE DYSFUNCTION  
This invention relates to the use of a fatty acid composition comprising at least (all-Z omega-3)-4,7,10,13,16,19-docosahexaenoic acid (DHA), or derivatives thereof, and (all-Z...
US20100080846 DIPYRIDAMOLE AND ACETYLSALICYLIC ACID FORMULATIONS AND PROCESS FOR PREPARING SAME  
The present invention provides pharmaceutical formulations of dipyridamole and acetylsalicylic acid, methods of making thereof, and methods of using thereof.
US20130004563 MULTIPARTICULATE S-ADENOSYLMETHIONINE COMPOSITIONS AND RELATED METHODS  
Multiparticulate compositions having S-adenosylmethionine an active ingredient are disclosed. The multiparticulates have spheroidal core comprising S-adenosylmethionine, microcrystalline...
US20120195963 HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES  
A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form...
US20140363502 Resveratrol-Containing Compositions and Methods of Use for Treatment of Macular Degeneration  
The present invention relates to a resveratrol-containing composition capable of modulating gene expression to an extent greater than that observed with resveratrol alone or with calorie...
US20110182983 HUMAN IMMORTALISED NEURAL PRECURSOR CELL LINE  
The present invention relates to an immortalised human neural precursor cell line, NGC-407. The cell line has been established from human foetal tissue. The cell line has been immortalised using a...
US20130129820 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE  
Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and R3 is a monocyclic heteroaryl group, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites...
US20080112989 Encapsulation method  
A method of loading liquid lipophilic compounds to capsules having a hydrogel shell and an oil core, wherein said compound, said capsules, and water and a solvent that is miscible with both water...
US20070122470 New Combination Dosage Form  
The present invention relates to an oral pharmaceutical preparation for use in the prevention and/or reduction of gastrointestinal complications associated with the use of acetyl salicylic acid....
US20060216345 Oral pharmaceutical composition including paroxetine  
A stable oral pharmaceutical composition including a therapeutically effective amount of paroxetine or its pharmaceutically acceptable salt and one or more adjuvants that prevent the formation of...
US20150132371 USE OF TOMATO EXTRACT AS ANTIHYPERTENSIVE AGENT AND PROCESS FOR MAKING WATER SOLUBLE SUGAR FREE TOMATO EXTRACT  
Provided herein is technology relating to tomato extracts and particularly, but not exclusively to preparing and using tomato extracts as an anti-hypertensive agent to modulate blood pressure.
US20080171084 Pharmaceutical semi-sold composition of isotretinoin  
An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an...
US20070104743 Formulations of fispemifene  
This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a mixture of isomers, a...
US20060141024 Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria  
The present invention relates to a method for preparation of synergistic combination kits of α,β-arteether, sulfadoxin and pyrimethamine for the treatment of severe/multi-drug resistant cerebral...
US20100055170 METAL CORE NANOCAPSULES  
Techniques for preparing nanocapsules are provided.
US20130230580 Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration  
Provided are therapeutics, uses and methods in which neuro-regenerative therapy using neuroprotective agents, or anti-neuropathic agents, to prevent loss or restore hematopoietic capacity and...
US20130164374 REDUCTION IN BACTERIAL COLONIZATION BY ADMINISTERING BACTERIOPHAGE COMPOSITIONS  
The present invention provides a method for reducing the risk of bacterial infection or sepsis in a susceptible patient by treating the susceptible patient with a pharmaceutical composition...
US20140186438 COMPOSITIONS COMPRISING EPA AND OBETICHOLIC ACID AND METHODS OF USE THEREOF  
In various embodiments, the present invention provides compositions comprising eicosapentaenoic acid or a derivative thereof and obeticholic acid or a derivative thereof. In other embodiments, the...
US20050181040 Progestagenic dosage unit  
The subject invention concerns a method of producing pharmaceutical dosage units for oral administration comprising a progestagenic compound which perorally exerts progestagenic activity...
US20050169981 Solid compositions comprising ramipril  
A solid pharmaceutical composition for oral administration that comprises a mixture of ramipril with lactose mono-hydrate.
US20130028969 METHOD FOR STABLE AND CONTROLLED DELIVERY OF (-)-HYDROXYCITRIC ACID  
The present invention provides stable encapsulated (−)-hydroxycitric acid (“HCA”)-containing compositions and methods of making the same. A method is provided by which the hygroscopic salts of HCA...